Part I: Assessment and Diagnostic Strategies for Neurogenic Bladder

Program Description:

Neurogenic bladder (NGB) affects many adults in the United States and is commonly caused by multiple sclerosis, spinal cord injury, cerebral vascular accident, and Parkinson’s disease. NGB patients with neurologic disorders often present with urinary symptoms, including urinary incontinence, urinary frequency, and urgency. The appropriate management of such patients includes accurate diagnosis and early identification of uninhibited bladder contraction, a comprehensive voiding workup and history, and the exploration of behavioral/lifestyle, pharmacologic, bladder injection, and surgical interventions.

INTENDED AUDIENCE:

This activity has been designed to meet the educational needs of urologists and other clinicians involved in the treatment of patients with bladder dysfunction.

Statement of Need:

Activity Objectives:

After completing the activity, the participant should be better able to:

• Identify patients for individualized treatment earlier using diagnostic strategies.


• Describe management options for neurogenic bladder, including evidence-based treatments and novel therapeutic approaches.





Credits	Type	Accreditation Statement	Designation Statement
1.00	AMA PRA Category 1 Credit(s)TM	This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide continuing medical education for physicians.	Medical Education Resources designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty:

David A. Ginsberg, MD
Associate Professor of Clinical Urology
Keck School of Medicine
University of Southern California
Los Angeles, California


Disclosures:

Disclosure of Conflicts of Interest
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosures
David A. Ginsberg, MD
Grants/Research Support: Allergan, Inc., Medtronic, Inc.
Consultant: Allergan, Inc., American Medical Systems, Inc.
Speakers’ Bureau: Allergan, Inc., Pfizer, Inc.

Publishing Staff Disclosures
The content managers, Roxanne Nelson, RN, Mary Jo Krey, Lori Marrese, Jody A. Charnow, and Marina Galanakis of Haymarket Medical Education, and Victoria C. Smith, MD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.

Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Medical Education Resources, Inc. (MER), and Haymarket Medical Education (HME) do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of MER and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Haymarket Medical Education, Inc., and/or Allergan. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, Haymarket Medical Education, Inc., and/or Allergan. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.


Accredited Provider:

Medical Education Resources and Haymarket Medical Education jointly sponsor this activity.

                 


Commercial Supporter:

This activity is supported by an educational grant from Allergan, Inc.



Instructions:

To obtain credit, a post-test score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

To view the myCME privacy policy, please click here. To view the Medical Education Resources privacy policy, please click here.

SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.